The health department has assured the public that South Africa is not facing a shortage of antiretroviral ARV medicines despite reports that two suppliers awarded contracts under the current ARV tender have entered business rescue.
Department spokesperson Foster Mohale said supply challenges linked to companies experiencing financial difficulties were not new and had long been anticipated in government procurement planning.
The department has historically maintained buffer stock to guard against supply disruptions, he said, adding that improved systems were now in place to achieve the same objective.
